18 and older, any sex, with Symptomatic Irreversible Pulpitis or Apical Periodontitis. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
24 Hour Postoperative Pain for Patients Seen From 09/2020-06/2021Primary· 24 hours post-operative
Postoperative Pain will be measured by the patient placing a mark that they feel best represents their level of pain on a 100mm Visual Analog Scale with 'No Pain' on the left (at 0) and 'Worst Pain Possible' on the right (at 100).
Group
Value
95% CI
GentleWave
14.75
± 17.91
EndoActivator
16.23
± 27.93
24 Hour Postoperative Pain for Patients Seen From 07/2021-03/2022Primary· 24 hr postoperatively
Postoperative Pain will be measured by the patient placing a mark that they feel best represents their level of pain on a 100mm Visual Analog Scale with 'No Pain' on the left (at 0) and 'Worst Pain Possible' on the right (at 100).
Group
Value
95% CI
GentleWave
12.86
± 18.65
EndoActivator
17.00
± 18.69
48 Hour Postoperative Pain for Patients Seen From 09/2020-06/2021Primary· 48 hours post-operative
Postoperative Pain will be measured by the patient placing a mark that they feel best represents their level of pain on a 100mm Visual Analog Scale with 'No Pain' on the left (at 0) and 'Worst Pain Possible' on the right (at 100).
Group
Value
95% CI
GentleWave
12.58
± 18.71
EndoActivator
11.73
± 19.58
48 Hour Postoperative Pain for Patients Seen From 07/2021-03/2022Primary· 48 hours post-operative
Postoperative Pain will be measured by the patient placing a mark that they feel best represents their level of pain on a 100mm Visual Analog Scale with 'No Pain' on the left (at 0) and 'Worst Pain Possible' on the right (at 100).
Group
Value
95% CI
GentleWave
6.86
± 12.35
EndoActivator
10.07
± 11.49
72 Hour Postoperative Pain for Patients Seen From 09/2020-06/2021Primary· 72 hour post-operative
Postoperative Pain will be measured by the patient placing a mark that they feel best represents their level of pain on a 100mm Visual Analog Scale with 'No Pain' on the left (at 0) and 'Worst Pain Possible' on the right (at 100).
Group
Value
95% CI
GentleWave
7.46
± 14.36
EndoActivator
7.30
± 13.14
72 Hour Postoperative Pain for Patients Seen From 07/2021-03/2022Primary· 72 hours post-operative
Postoperative Pain will be measured by the patient placing a mark that they feel best represents their level of pain on a 100mm Visual Analog Scale with 'No Pain' on the left (at 0) and 'Worst Pain Possible' on the right (at 100).
Group
Value
95% CI
GentleWave
3.57
± 4.89
EndoActivator
5.86
± 10.85
96 Hour Postoperative Pain for Patients Seen From 09/2020-06/2021Primary· 96 hours post-operative
Postoperative Pain will be measured by the patient placing a mark that they feel best represents their level of pain on a 100mm Visual Analog Scale with 'No Pain' on the left (at 0) and 'Worst Pain Possible' on the right (at 100).
Group
Value
95% CI
GentleWave
9.96
± 19.98
EndoActivator
7.53
± 16.15
96 Hour Postoperative Pain for Patients Seen From 07/2021-03/2022Primary· 96 hours post-operative
Postoperative Pain will be measured by the patient placing a mark that they feel best represents their level of pain on a 100mm Visual Analog Scale with 'No Pain' on the left (at 0) and 'Worst Pain Possible' on the right (at 100).
Each tooth root was classified as healed (no periapical radiolucency), healing (periapical radiolucency educed in size), or diseased (periapical radiolucency same size or larger). Pre-operative vs. post-operative periapical health evaluated using radiographs to compare the size of periapical radiolucencies present pre-op vs post-op.
Healed
Group
Value
95% CI
GentleWave
24
EndoActivator
24
Healing
Group
Value
95% CI
GentleWave
4
EndoActivator
4
Diseased
Group
Value
95% CI
GentleWave
0
EndoActivator
4
Clinical Tooth Healing Classification Based on Clinical Examination and Patient ReportPrimary· 12-month recall
Teeth were classified as being clinically successful if the patient had no symptoms other than mild tenderness to percussion. Teeth were classified as failures if outside these parameters.
Success
Group
Value
95% CI
GentleWave
12
EndoActivator
12
Failure
Group
Value
95% CI
GentleWave
0
EndoActivator
2
Pain Pill Consumption for Patients Seen From 09/2021-06/2021Secondary· Patient to record on the Pain Pill Log each time that they take a pain pill during the 4 days following their root canal treatment.
Patients will be given 16 tabs of 600mg Ibuprofen and 16 tabs of 650mg Acetaminophen with instructions to take 1 pill every 6 hours as needed for pain. Patients will be given a Pain Pill Log to record each time they take a pill. The total number of pills consumed will be tabulated for each patient.
Group
Value
95% CI
GentleWave
5.08
± 4.56
EndoActivator
6.63
± 7.63
Pain Pill Consumption for Patients Seen From 07/2021-03/2022Secondary· Patient to record on the Pain Pill Log each time that they take a pain pill during the 4 days following their root canal treatment.
Patients will be given 16 tabs of 600mg Ibuprofen and 16 tabs of 650mg Acetaminophen with instructions to take 1 pill every 6 hours as needed for pain. Patients will be given a Pain Pill Log to record each time they take a pill. The total number of pills consumed will be tabulated for each patient.
Group
Value
95% CI
GentleWave
4.00
± 3.82
EndoActivator
4.93
± 8.02
Sponsor's own description
Patients with painful molars will be randomly assigned to 2 different groups: GentleWave and EndoActivator. The root canals will be completed using identical protocols except in the mode of delivery and activation of irrigation (using either the GentleWave or EndoActivator). Postoperative pain and pain pill consumption will be measured for the 4 days following their root canal using a Visual Analog Scale and Pain Pill Log, respectively. The alternative hypothesis is that patients undergoing treatment using the GentleWave will experience less pain postoperatively and will consume fewer pain pills.
A 12-month follow up with exam and radiographs will be completed to evaluate healing.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Other recruiting trials for Symptomatic Irreversible Pulpitis
Currently open trials in the same condition.
NCT07410780 — Postoperative Pain After Root Canal Obturation Using Bioceramic and Calcium Hydroxide Sealers
· NA
· recruiting
NCT07290049 — Postoperative Pain After Pulpotomy in Children Using Calcium Silicate Cements With and Without Laser Therapy
· NA
· recruiting
NCT06640231 — The Effect of XP-Endo Finisher Activation of Bioceramic Sealer on Postoperative Pain in Mandibular First Molar With Symp
· NA
· recruiting
NCT06525844 — Regenerative Endodontic Therapy in Cases of Irreversible Pulpitis
· NA
· recruiting
Other St. Louis University trials
Trials by the same sponsor.
NCT07024940 — Short-term Effects of Caffeine and a Multi-ingredient Pre-workout on Exercise Performance
· NA
· recruiting
NCT06859528 — Step Up to PD: A Community-based Walking Program for People With Parkinson's Disease
· NA
· recruiting
NCT04158037 — Don't Go There: A Geospatial mHealth App for Gambling Disorder
· NA
· withdrawn
NCT05406310 — Clinical Outcomes of Persistent Atrial Fibrillation Ablation Using Ablation Index-guided Radiofrequency Catheter Ablatio
· withdrawn
NCT05854836 — Preconception Intervention for Incarcerated Women With Substance Use
· NA
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by St. Louis University
Last refreshed: 15 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04552132.